Early immunohistochemistry studies of pulmonary LCNEC also showed this dichotomy, demonstrating alterations of RB1 and TP53 common in SCLC with other samples lacking alterations of RB1 or TP53. This evidence concerns the gene RB1 and large cell neuroendocrine carcinoma.